We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

This study has been terminated.
(Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01281254
First Posted: January 21, 2011
Last Update Posted: May 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Amgen
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 19, 2017
  Primary Completion Date: August 29, 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: April 23, 2015